Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA: 688506)

Market Cap	78.85B
Revenue (ttm)	5.85B
Net Income (ttm)	3.80B
Shares Out	401.00M
EPS (ttm)	9.52
PE Ratio	20.65
Forward PE	20.91
Dividend	n/a
Ex-Dividend Date	n/a

Volume	925,248
Open	199.50
Previous Close	199.50
Day's Range	196.07 - 200.12
52-Week Range	96.21 - 246.31
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 28, 2025

About Sichuan Biokin Pharmaceutical Co.,Ltd.

Sichuan Biokin Pharmaceutical Co.,Ltd. engages in the research and development, production, and marketing of small molecule chemical, macromolecular biological, and antibody-drug conjugate drugs in China and internationally. Sichuan Biokin Pharmaceutical Co.,Ltd. was founded in 2006 and is based in Chengdu, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2006
• Employees: 2,086
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688506

Financial Performance

In 2023, Sichuan Biokin Pharmaceutical Co.,Ltd.'s revenue was 561.87 million, a decrease of -20.11% compared to the previous year's 703.28 million. Losses were -780.50 million, 176.4% more than in 2022.